Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 238,263,106 papers from all fields of science
Search
Sign In
Create Free Account
fingolimod
Known as:
Fingolimodum
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Narrower (3)
FTY-720
Gilenya
fingolimod hydrochloride
fingolimod 0.5 MG Oral Capsule [Gilenya]
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A Likelihood to Achieve No Evidence of Disease Activity or Harm Analysis
D. Papadopoulos
,
D. Mitsikostas
CNS Drugs
2018
Corpus ID: 51893309
BackgroundThe likelihood to help or harm (LHH) is an absolute measure of the benefit versus risk profile of a medication, which…
Expand
Review
2016
Review
2016
Switching from Natalizumab to Fingolimod : Case Report and Review of Literature
S. J. Clark
,
Wang Qin
,
Y. Mao-Draayer
2016
Corpus ID: 32902721
Cite this article: Clark SJ, Wang Q, Mao-Draayer Y (2016) Switching from Natalizumab to Fingolimod: Case Report and Review of…
Expand
Review
2016
Review
2016
Early Relapsing Multiple Sclerosis
David E. Jones
Continuum
2016
Corpus ID: 22921830
Purpose of Review:This article provides an evidence-based approach to the management of patients with early relapsing multiple…
Expand
2015
2015
End-organ damage in diabetes : Exploring innovative targets and therapies
M. H. Shishavan
2015
Corpus ID: 23599004
Diabetes mellitus (DM) affects the function of blood vessels and various organs, eventually leading to life-threatening DM…
Expand
2015
2015
36 month PANGAEA: A 5-year non-interventional study of safety, efficacy and pharmacoeconomic data for fingolimod patients in daily clinical practice (P3.251)
T. Ziemssen
2015
Corpus ID: 68485893
OBJECTIVE: PANGAEA (Post-Authorization Non-interventional German sAfety study of GilEnyA in RRMS patients) is a non…
Expand
Review
2014
Review
2014
Neuro-Ophthalmic Literature Review
Carmen K. M. Chan
,
A. Petzold
,
+4 authors
An-Guor Wang
2014
Corpus ID: 196417555
Neuro-Ophthalmic Literature Review Carmen K. M. Chan, Axel Petzold, Evan Price, John H. Pula, Matthieu Robert, Michael Vaphiades…
Expand
Review
2013
Review
2013
Multiple Sclerosis Research: Diagnostics, Disease-Modifying Treatments, and Emerging Therapies
K. Costello
Journal of Neuroscience Nursing
2013
Corpus ID: 24432818
ABSTRACT Multiple sclerosis (MS) is a complex disease that affects the central nervous system. It is believed to be an immune…
Expand
2012
2012
S 1 P 1 Receptor Modulation with Cyclical Recovery from Lymphopenia Ameliorates Mouse Model of Multiple Sclerosis
P. Gonzalez-Cabrera
,
Stuart M. Cahalan
,
+5 authors
H. Rosen
2012
Corpus ID: 6808959
Multiple sclerosis (MS) therapies modulate T-cell autoimmunity in the central nervous system (CNS) but may exacerbate latent…
Expand
2011
2011
Synthesis of Fingolimod
Chong-Quan Zhu
2011
Corpus ID: 98890686
Fingolimod was synthesized from 1-phenyloctane and 3-bromopropionylchloride by Friedel-Crafts acylation,nitration,reduction…
Expand
2008
2008
Fingolimod Suppresses Disease Activity in Relapsing‐Remitting MS: But Safety Concerns Are Identified
A. Goodman
2008
Corpus ID: 71125410
mune-modulating drug, fingolimod (FTY 720) seems promising as a treatment for relapsing-remitting multiple sclerosis (RRMS…
Expand